HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Mortimer, A. M. Search for Related Content PubMed Articles by Mortimer, A. M.

Symptom rating scales and outcome in schizophrenia

Department of Psychiatry, University of Hull, Hertford Building, Cottingham Road, Hull HU6 7RX. Email: a.m.mortimer{at}hull.ac.uk

Declaration of interest A.M.M. has received funding from several pharmaceutical companies.

Background Symptom rating scales are now well established in schizophrenia research but their scores are not the same as outcome.

Aims To appraise the usefulness of symptom rating scales in evaluating the outcome of people with schizophrenia.

Method Literature on the use of the Brief Psychiatric Rating Scale (BPRS) the Positive and Negative Syndrome Scale (PANSS) and the Clinical Global Impression (CGI) in schizophrenia research was studied.

Results Scales were designed to make diagnoses, to categorise patients, syndromes or both, and to demonstrate antipsychotic efficacy, as well as to measure outcome. There is much redundancy both between and within scales. Early work suggests limited concurrent validity with external outcome variables. Data are at best ordinal and there are particular difficulties in equating outcome with percentage changes in scores. The concept of remission, which uses absolute item score thresholds with a duration criterion, is a promising outcome measure.

Conclusions Symptom rating scale scores can only comprise a limited part of outcome measurement. Standardised remission criteria may present advantages in outcome research.

This article has been cited by other articles:

				T. Burns Evolution of outcome measures in schizophrenia The British Journal of Psychiatry, August 1, 2007; 191(50): s1 - s6. [Abstract] [Full Text] [PDF]